Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Titel:
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Auteur:
Köhne, C.-H. De Greve, J. Hartmann, J.T. Lang, I. Vergauwe, P. Becker, K. Braumann, D. Joosens, E. Müller, L. Janssens, J. Bokemeyer, C. Reimer, P. Link, H. Späth-Schwalbe, E. Wilke, H.-J. Bleiberg, H. Van Den Brande, J. Debois, M. Bethe, U. Van Cutsem, E.